DK1960370T3 - Pyridazinonderivater til tumorbehandling - Google Patents
Pyridazinonderivater til tumorbehandlingInfo
- Publication number
- DK1960370T3 DK1960370T3 DK06806700.8T DK06806700T DK1960370T3 DK 1960370 T3 DK1960370 T3 DK 1960370T3 DK 06806700 T DK06806700 T DK 06806700T DK 1960370 T3 DK1960370 T3 DK 1960370T3
- Authority
- DK
- Denmark
- Prior art keywords
- tumor treatment
- pyridazinone derivatives
- pyridazinone
- derivatives
- tumor
- Prior art date
Links
- AAILEWXSEQLMNI-UHFFFAOYSA-N 1h-pyridazin-6-one Chemical class OC1=CC=CN=N1 AAILEWXSEQLMNI-UHFFFAOYSA-N 0.000 title 1
- 206010028980 Neoplasm Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/14—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102005057924A DE102005057924A1 (de) | 2005-12-05 | 2005-12-05 | Pyridazinonderivate |
| PCT/EP2006/010668 WO2007065518A1 (de) | 2005-12-05 | 2006-11-07 | Pyridiazinonderivate zur behandlung von tumoren |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1960370T3 true DK1960370T3 (da) | 2012-01-02 |
Family
ID=37775213
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK06806700.8T DK1960370T3 (da) | 2005-12-05 | 2006-11-07 | Pyridazinonderivater til tumorbehandling |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US8173653B2 (da) |
| EP (1) | EP1960370B1 (da) |
| JP (1) | JP5210172B2 (da) |
| KR (1) | KR101367447B1 (da) |
| CN (1) | CN101326167B (da) |
| AR (1) | AR057214A1 (da) |
| AT (1) | ATE527241T1 (da) |
| AU (1) | AU2006322364B2 (da) |
| BR (1) | BRPI0619407A2 (da) |
| CA (1) | CA2632217C (da) |
| CY (1) | CY1112206T1 (da) |
| DE (1) | DE102005057924A1 (da) |
| DK (1) | DK1960370T3 (da) |
| EA (1) | EA014667B1 (da) |
| EC (1) | ECSP088598A (da) |
| ES (1) | ES2373117T3 (da) |
| HK (1) | HK1127489A1 (da) |
| IL (1) | IL191832A (da) |
| MY (1) | MY153261A (da) |
| NZ (1) | NZ569568A (da) |
| PE (1) | PE20070832A1 (da) |
| PL (1) | PL1960370T3 (da) |
| PT (1) | PT1960370E (da) |
| SI (1) | SI1960370T1 (da) |
| TW (1) | TWI395741B (da) |
| UA (1) | UA95934C2 (da) |
| WO (1) | WO2007065518A1 (da) |
| ZA (1) | ZA200805877B (da) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5335675B2 (ja) * | 2006-07-25 | 2013-11-06 | セファロン、インク． | ピリジジノン誘導体 |
| DE102006037478A1 (de) * | 2006-08-10 | 2008-02-14 | Merck Patent Gmbh | 2-(Heterocyclylbenzyl)-pyridazinonderivate |
| PL2094662T3 (pl) * | 2006-12-14 | 2012-09-28 | Astellas Pharma Inc | Związki oparte na policyklicznych kwasach użyteczne jako antagoniści rCRTH2 oraz jako środki przeciwalergiczne |
| US8283351B2 (en) * | 2007-04-02 | 2012-10-09 | Institute For Oneworld Health | Cyclic and acyclic hydrazine derivatives compositions including them and uses thereof |
| DE102007025717A1 (de) * | 2007-06-01 | 2008-12-11 | Merck Patent Gmbh | Arylether-pyridazinonderivate |
| DE102007025718A1 (de) * | 2007-06-01 | 2008-12-04 | Merck Patent Gmbh | Pyridazinonderivate |
| DE102007026341A1 (de) | 2007-06-06 | 2008-12-11 | Merck Patent Gmbh | Benzoxazolonderivate |
| DE102007032507A1 (de) | 2007-07-12 | 2009-04-02 | Merck Patent Gmbh | Pyridazinonderivate |
| DE102007038957A1 (de) * | 2007-08-17 | 2009-02-19 | Merck Patent Gmbh | 6-Thioxo-pyridazinderivate |
| DE102007061963A1 (de) * | 2007-12-21 | 2009-06-25 | Merck Patent Gmbh | Pyridazinonderivate |
| CN101538245B (zh) * | 2008-03-18 | 2011-02-16 | 中国科学院上海药物研究所 | 一类哒嗪酮类化合物及其制备方法和制备药物的用途 |
| DE102008019907A1 (de) | 2008-04-21 | 2009-10-22 | Merck Patent Gmbh | Pyridazinonderivate |
| DE102008028905A1 (de) | 2008-06-18 | 2009-12-24 | Merck Patent Gmbh | 3-(3-Pyrimidin-2-yl-benzyl)-[1,2,4]triazolo[4,3-b]pyridazinderivate |
| DE102008037790A1 (de) | 2008-08-14 | 2010-02-18 | Merck Patent Gmbh | Bicyclische Triazolderivate |
| CN102264729B (zh) * | 2008-12-22 | 2014-03-05 | 默克专利有限公司 | 6-(1-甲基-1h-吡唑-4-基)-2-{3-[5-(2-吗啉-4-基-乙氧基)-嘧啶-2-基]-苄基}-2h-哒嗪-3-酮磷酸二氢盐的多晶型物及其制备方法 |
| DE102008062826A1 (de) | 2008-12-23 | 2010-07-01 | Merck Patent Gmbh | Pyridazinonderivate |
| DE102009003954A1 (de) | 2009-01-07 | 2010-07-08 | Merck Patent Gmbh | Pyridazinonderivate |
| DE102009004061A1 (de) | 2009-01-08 | 2010-07-15 | Merck Patent Gmbh | Pyridazinonderivate |
| EA019342B1 (ru) | 2009-01-08 | 2014-02-28 | Мерк Патент Гмбх | Новые полиморфные формы гидрохлоридной соли 3-(1-{3-[5-(1-метилпиперидин-4-илметокси)пиримидин-2-ил]бензил}-6-оксо-1,6-дигидропиридазин-3-ил)бензонитрила и способы их получения |
| CN102731409A (zh) * | 2011-04-08 | 2012-10-17 | 中国科学院上海药物研究所 | 一类哒嗪酮类化合物，其药物组合物、制备方法及用途 |
| KR101842645B1 (ko) | 2012-04-12 | 2018-03-29 | 한국화학연구원 | 신규한 히드라진온이 치환된 피리미딘 유도체 및 그의 용도 |
| SI2914264T1 (sl) * | 2012-11-02 | 2017-12-29 | Merck Patent Gmbh | 6-okso-1,6-dihidro-piridazinski derivat za uporabo za zdravljenje hepatocelularnega karcinoma (hcc) |
| PE20180248A1 (es) * | 2013-10-18 | 2018-02-02 | Celgene Quanticel Res Inc | Inhibidores de bromodominio |
| CN103772352B (zh) * | 2014-01-16 | 2017-01-18 | 四川百利药业有限责任公司 | 哒嗪酮类衍生物及其制备方法和用途 |
| ES2945865T3 (es) * | 2014-12-11 | 2023-07-10 | Merck Patent Gmbh | Combinación de un derivado de 6-oxo-1,6-dihidropiridazina que tiene actividad anticancerígena con un derivado de quinazolina |
| US20190248765A1 (en) * | 2016-10-26 | 2019-08-15 | Proteostasis Therapeutics, Inc. | Compounds, compositions, and methods for increasing cftr activity |
| CN107334767B (zh) * | 2017-06-08 | 2019-03-05 | 中国医学科学院医药生物技术研究所 | 一种哒嗪酮类化合物在肿瘤治疗中的应用 |
| CN111315735B (zh) * | 2017-09-04 | 2024-03-08 | C4医药公司 | 二氢苯并咪唑酮 |
| AU2019374812B2 (en) * | 2018-11-06 | 2025-03-06 | Edgewise Therapeutics, Inc. | Pyridazinone compounds and uses thereof |
| EP4248972A3 (en) | 2018-11-06 | 2023-12-06 | Edgewise Therapeutics, Inc. | Pyridazinone compounds and uses thereof |
| EP3877376B1 (en) | 2018-11-06 | 2023-08-23 | Edgewise Therapeutics, Inc. | Pyridazinone compounds and uses thereof |
| WO2020181232A1 (en) | 2019-03-06 | 2020-09-10 | C4 Therapeutics, Inc. | Heterocyclic compounds for medical treatment |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RO79566A2 (ro) * | 1980-05-28 | 1982-08-17 | Institutul De Cercetari Chimico-Farmaceutice,Ro | Substante din clasa 2-(3'-aril-piridazonil-1'5-metil-5-aril-(alchil)amino-tiadiazolului |
| RO79562A2 (ro) * | 1980-05-29 | 1982-08-17 | Institutul De Cercetari Chimico-Farmaceutice,Ro | Substante din clasa 3-(3'-aril-piridazonil-1'5-metil-4-aril(alchil)-5-mercapto-1,2,4-triazolului si procedeu de obtinere a acestora |
| JPS5826802A (ja) * | 1981-08-10 | 1983-02-17 | Sankyo Co Ltd | 農園芸用殺菌剤 |
| DE3321012A1 (de) * | 1983-06-10 | 1984-12-13 | A. Nattermann & Cie GmbH, 5000 Köln | Substituierte 4,5-dihydro-6-(thien-2-yl)-3(2h)-pyridazinone und 6-(thien-2-yl)-3(2h)-pyridazinone sowie verfahren zu ihrer herstellung |
| ES2131506T3 (es) * | 1990-09-21 | 1999-08-01 | Rohm & Haas | Dihidropiridacinonas y piridacinonas como fungicidas. |
| IE913310A1 (en) * | 1990-09-21 | 1992-02-25 | Rohm & Haas | Dihydropyridazinones, pyridazinones and related compounds as¹fungicides |
| AU691673B2 (en) * | 1994-11-14 | 1998-05-21 | Dow Agrosciences Llc | Pyridazinones and their use as fungicides |
| US6121251A (en) * | 1996-10-11 | 2000-09-19 | Rohm And Haas Company | Dihydropyridazinones and pyridazinones and their use as fungicides and insecticides |
| DE69833774T2 (de) * | 1997-08-22 | 2007-04-26 | Abbott Laboratories, Abbott Park | Prostaglandin endoperoxyde h synthase biosynthese inhibitoren |
| EP1043317B1 (en) * | 1997-11-19 | 2009-04-15 | Kowa Co., Ltd. | Pyridazine derivatives and medicaments containing them as active ingredient |
| US7060822B1 (en) * | 1999-07-30 | 2006-06-13 | Abbott Gmbh & Co. Kg | 2-pyrazolin-5-ones |
| IL147757A0 (en) * | 1999-07-30 | 2002-08-14 | Abbott Gmbh & Co Kg | 2-pyrazolin-5-ones |
| AUPR606401A0 (en) | 2001-07-02 | 2001-07-26 | Fujisawa Pharmaceutical Co., Ltd. | Pyrazolopyridine compound and pharmaceutical use thereof |
| WO2003037349A1 (en) * | 2001-10-31 | 2003-05-08 | Merck Patent Gmbh | Type 4 phosphodiesterase inhibitors and uses thereof |
| CA2474239A1 (en) * | 2002-01-18 | 2003-07-24 | Pharmacia Corporation | Substituted pyridazinones as inhibitors of p38 |
| US20040067955A1 (en) * | 2002-09-06 | 2004-04-08 | Fujisawa Pharmaceutical Co. Ltd. | Pyridazinone compound and pharmaceutical use thereof |
| US7314877B2 (en) * | 2003-03-07 | 2008-01-01 | Kowa Co., Ltd. | Benzofuran derivative |
| KR20060028632A (ko) * | 2003-04-25 | 2006-03-30 | 길리애드 사이언시즈, 인코포레이티드 | 항염증 포스포네이트 화합물 |
| CN101410120A (zh) * | 2003-04-25 | 2009-04-15 | 吉里德科学公司 | 抗炎的膦酸酯化合物 |
| WO2006095666A1 (ja) * | 2005-03-07 | 2006-09-14 | Kyorin Pharmaceutical Co., Ltd. | ピラゾロピリジン－４－イルピリダジノン誘導体とその付加塩及びそれらを有効成分とするｐｄｅ阻害剤 |
-
2005
- 2005-12-05 DE DE102005057924A patent/DE102005057924A1/de not_active Withdrawn
-
2006
- 2006-11-07 KR KR1020087016217A patent/KR101367447B1/ko not_active Expired - Fee Related
- 2006-11-07 JP JP2008543675A patent/JP5210172B2/ja not_active Expired - Fee Related
- 2006-11-07 MY MYPI20081936A patent/MY153261A/en unknown
- 2006-11-07 UA UAA200808757A patent/UA95934C2/ru unknown
- 2006-11-07 CA CA2632217A patent/CA2632217C/en active Active
- 2006-11-07 SI SI200631187T patent/SI1960370T1/sl unknown
- 2006-11-07 ES ES06806700T patent/ES2373117T3/es active Active
- 2006-11-07 NZ NZ569568A patent/NZ569568A/en not_active IP Right Cessation
- 2006-11-07 US US12/096,079 patent/US8173653B2/en not_active Expired - Fee Related
- 2006-11-07 PL PL06806700T patent/PL1960370T3/pl unknown
- 2006-11-07 DK DK06806700.8T patent/DK1960370T3/da active
- 2006-11-07 AU AU2006322364A patent/AU2006322364B2/en not_active Ceased
- 2006-11-07 CN CN2006800458935A patent/CN101326167B/zh not_active Expired - Fee Related
- 2006-11-07 BR BRPI0619407-9A patent/BRPI0619407A2/pt not_active Application Discontinuation
- 2006-11-07 EP EP06806700A patent/EP1960370B1/de active Active
- 2006-11-07 EA EA200801428A patent/EA014667B1/ru not_active IP Right Cessation
- 2006-11-07 AT AT06806700T patent/ATE527241T1/de active
- 2006-11-07 PT PT06806700T patent/PT1960370E/pt unknown
- 2006-11-07 WO PCT/EP2006/010668 patent/WO2007065518A1/de active Application Filing
- 2006-12-01 AR ARP060105310A patent/AR057214A1/es active IP Right Grant
- 2006-12-04 TW TW095145046A patent/TWI395741B/zh not_active IP Right Cessation
- 2006-12-05 PE PE2006001553A patent/PE20070832A1/es active IP Right Grant
-
2008
- 2008-05-29 IL IL191832A patent/IL191832A/en active IP Right Grant
- 2008-07-02 EC EC2008008598A patent/ECSP088598A/es unknown
- 2008-07-04 ZA ZA200805877A patent/ZA200805877B/xx unknown
-
2009
- 2009-06-09 HK HK09105156.0A patent/HK1127489A1/xx not_active IP Right Cessation
-
2011
- 2011-12-14 CY CY20111101245T patent/CY1112206T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1960370T3 (da) | Pyridazinonderivater til tumorbehandling | |
| DK3424932T3 (da) | Bronophthalider til terapeutisk anvendelse | |
| ATE525088T1 (de) | Kombinationstherapie | |
| ATE520670T1 (de) | Pyridazinderivate | |
| NL1029015A1 (nl) | Therapeutische verbindingen. | |
| HUE054495T2 (hu) | Rák kezelésére szolgáló készítmény | |
| DE602006004866D1 (de) | Katheter | |
| DK3457135T3 (da) | Behandlingsmuligheder til fabrys sygdom | |
| DK1765391T3 (da) | Bakterielle præparater til behandlingen af cancer | |
| DK1879623T3 (da) | Genterapi til rygmarvssygdomme | |
| LT3312197T (lt) | Monokloniniai antikūnai prieš klaudiną 18, skirti vėžio gydymui | |
| SMP200900085B (it) | 3-imidazolil-indoli per il trattamento di malattieproliferative. | |
| DK2426106T3 (da) | Piperidin- og piperazinderivat til behandling af tumorer | |
| DK3567035T3 (da) | N-substituerede 2,5-dioxo-azolin-forbindelser til anvendelse ved behandling af cancer | |
| IL188430A0 (en) | Treatment of tumors | |
| DK2121139T3 (da) | Formulations for cancer treatment | |
| DK3403657T3 (da) | Anvendelse af oligouronater til behandling af slimhyperviskositet | |
| NO20070251A (no) | Brønnbehandling | |
| NO20070297A (no) | Brønnbehandling | |
| DK1863899T3 (da) | Hudbehandlingspræparater | |
| FR2872704B1 (fr) | Pluritherapie contre le cancer | |
| DK2056842T3 (da) | Modificeret galactosylceramid til behandling af cancerøse sygdomme | |
| DE602006019395D1 (de) | Media-behandlungseinrichtung | |
| DE602006013094D1 (de) | Krebsmittel | |
| DK2147122T3 (da) | Enzymatisk kræftbehandling |